logo

BLTE

Belite Bio·NASDAQ
--
--(--)
--
--(--)
7.45 / 10
Outperform

Analyst consensus is strongly positive (33% Strong Buy, 66% Buy) and sentiment scores 7.45/10. Fund‑flow rating is good (7.76), with overall and extra‑large inflows positive but small, medium and large segments negative. Momentum remains favorable.

FundamentalSentiment(7.45)Technical
Fund Flow Rating
Analyst RatingBuy

Wall Street Opinions

Buy

Strong Buy

33%

Buy

67%

Hold

0%

Sell

0%

Strong Sell

0%

Date2026-03-03
InstitutionMorgan Stanley
Times predicted2
Historical Win Rate50.0%
What is the market sentiment for BLTE?
  • BLTE holds a Bullish analyst rating, with 67% of experts assigning a Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 7.45/10 (Outperform).